Daily summary: Wall Street at record high despite dour jobs report

7:13 PM 4 December 2020
  • US major indices shrug off the weaker jobs data
  • US lawmakers resume stimulus talks
  • OPEC+ agrees to gradual output hike
European indices finished today's session higher with DAX 30 adding 0.2% to 13,282, helped by upbeat German factory orders data. CAC 40 rose 0.61% and  FTSE 100 finished 0.90% higher. Meanwhile news about Poland showing willingness to find a solution that would allow an agreement to be reached on the EU's €1.8 trillion stimulus package turned out to be short-lived. A deputy Polish prime minister appeared to suggest Thursday that Poland was willing to compromise, words that some understood as Poland softening its position. But a deputy foreign minister told The Associated Press on Friday that Poland’s position remains as it has been from the beginning. The deadline for the European Parliament and member states to reach an agreement on the annual budget is December 7th. On the Brexit front, EU official announced a deal was closer than ever but a UK government source warned chances for a breakthrough in the next few days were receding.

Wall Street's main indexes jumped to all-time highs on Friday despite weak NFP report which showed that US economy added only 245,000 jobs in November. That’s well below analysts' consensus estimate of 469,000. The unemployment rate fell to 6.7% from 6.9%. However, some investors consider disappointing NFP number as a positive because it could put additional pressure on politicians to move forward with stimulus negotiations. US House Speaker Pelosi and Senate Majority Leader Mitch McConnell resumed phone talks on Thursday. Today Pelosi said “there is momentum” toward a coronavirus stimulus deal. Lawmakers also face a Dec. 11 deadline to pass a $1.4 trillion budget or risk a shutdown of the government. Meanwhile the number of COVID-19 infections continues to accelerate sharply. Yesterday US reported record numbers of new daily infections, single-day deaths and hospitalizations. Today US Food and Drug Administration's chief said he had a "robust discussion" with the White House this week about the timeline for COVID-19 vaccine approvals and believes vaccinating 20 million Americans this year is realistic. Yesterday Dow Jones reported, that Pfizer expects to ship half of the Covid-19 vaccines it originally planned for this year due to supply-chain problems. However company is still planning to roll out 1.3 billion vaccines next year and the 50 million dose shortfall this year will be covered as production ramps up, the report said.

US crude cut some of the early gains and is trading  0.5% higher at $45.89 a barrel, while the international benchmark Brent contract rose over 0.5% to $48.95. OPEC+ agreed to raise crude output by only 500,000 barrels a day in January, far below the 2 million barrels a day initially proposed. Delegates failed to reach an agreement regarding broader policy for the rest of next year. Ministers will now hold monthly consultations to determine how to adjust production in subsequent months.Elsewhere, gold futures rose 0.25% to $1,837.00/oz, while silver rose 0.2% to $24.10.
Silver – price has been trading in a local sideways move since Wednesday. Commodity is struggling to break above the 50 SMA (green line) which also coincides with lower limit of the earlier broken triangle pattern. Should buyers fail to break above it, a near-term support at $22.15 could be at risk. Source: xStation5
Share:
Back
Xtb logo

Join over 1 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
test_cookie cc 25 January 2024
adobe_unique_id cc 1 March 2025
__hssc cc 8 September 2022
SESSID cc 2 March 2024
__cf_bm cc 8 September 2022
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
_gid cc 9 September 2022
_gat_UA-98728395-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_gcl_au cc 30 May 2024
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
__hstc cc 7 March 2023
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 7 March 2023

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language